Medtronic PLC  

(Public, NYSE:MDT)   Watch this stock  
Find more results for Carol L. Hanson�
+1.09 (1.54%)
After Hours: 72.05 +0.02 (0.03%)
Oct 8, 4:33PM EDT  
NYSE real-time data - Disclaimer
Currency in USD
Range 70.12 - 72.18
52 week 55.54 - 79.50
Open 70.34
Vol / Avg. 6.66M/8.05M
Mkt cap 100.80B
P/E 30.20
Div/yield 0.38/2.11
EPS 2.39
Shares 1.41B
Beta 1.10
Inst. own 84%
Dec 11, 2015
Medtronic PLC Annual Shareholders Meeting - 4:00AM EST - Add to calendar
Oct 14, 2015
Medtronic PLC Cardiac & Vascular Group Investor Briefing - 8:00PM EDT - Add to calendar
Sep 17, 2015
Medtronic PLC at Morgan Stanley Healthcare Conference - Webcast
Sep 9, 2015
Medtronic PLC at Wells Fargo Healthcare Conference
Sep 3, 2015
Q1 2016 Medtronic PLC Earnings Call - Webcast
Sep 3, 2015
Q1 2016 Medtronic PLC Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Jul '15) 2015
Net profit margin 11.27% 13.20%
Operating margin 15.55% 19.62%
EBITD margin - 29.97%
Return on average assets 2.89% 3.70%
Return on average equity 5.76% 7.36%
Employees 92,000 -
CDP Score - 81 D


20 On Hatch, Hatch Street Lower
+353-1-4381700 (Phone)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Medtronic plc (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. Medtronic, Inc. is a subsidiary of the Company.

Officers and directors

Omar Ishrak Chairman of the Board, Chief Executive Officer
Age: 59
Bio & Compensation  - Reuters
Gary L. Ellis Chief Financial Officer, Senior Vice President, Director
Age: 58
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Carol A. Surface Chief Human Resource Officer, Senior Vice President
Age: 49
Bio & Compensation  - Reuters
Michael J. Coyle Executive Vice President, Group President - Cardiac and Vascular Group
Age: 52
Bio & Compensation  - Reuters
Hooman C. Hakami Executive Vice President and Group President of the Medtronic Diabetes Group
Age: 45
Bio & Compensation  - Reuters
Bryan C. Hanson Executive Vice President, Group President - Minimally Invasive Therapies Group
Age: 48
Bio & Compensation  - Reuters
Robert ten Hoedt Executive Vice President and President, EMEAC
Age: 54
Bio & Compensation  - Reuters
Geoff Martha Executive Vice President and President - Restorative Therapies Group
Bio & Compensation  - Reuters
Bradley E. Lerman Senior Vice President, General Counsel, Corporate secretary, Director
Age: 58
Bio & Compensation  - Reuters
Geoffrey S. Martha Senior Vice President - Strategy and Business Development
Age: 45
Bio & Compensation  - Reuters